Efficacy and Safety of Early Use of Everolimus in Standard and Extended Criteria Deceased Donor KidneyTransplant Recipients: 12-Month Preliminary Results of a Randomized Single Center Trial.

被引：0
|
作者：
Fernandes-Charpiot, I. [1 ,2 ]
Caldas, H. [2 ]
Mazeti, C. [2 ]
Baptista, M. [1 ,2 ]
Razera, J. [2 ]
Abbud-Filho, M. [1 ,2 ,3 ]
机构：
[1] Sao Jose do Rio Preto, Hosp Base, Fac Med, Sao Paulo, Brazil
[2] Sao Jose do Rio Preto, Lab Imunolgia & Transplante Expt, Sao Paulo, Brazil
[3] Sao Jose do Rio Preto, Inst Urol & Nefrol, Sao Paulo, Brazil
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
C1859
引用
收藏
页码：597 / 598
页数：2
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF EARLY USE OF REDUCED TACROLIMUS IN COMBINATION WITH EVEROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVERTRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA
    Schemmer, Peter
    Braun, Felix
    Schlitt, Hans J.
    Pascher, Andreas
    Klein, Christian-Georg
    Neumann, Ulf
    Kroeger, Irena
    Wimmer, Peter
    Nashan, Bjoern
    TRANSPLANT INTERNATIONAL, 2019, 32 : 218 - 219
  • [32] Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial
    Favi, Evaldo
    Spagnoletti, Gionata
    Salerno, Maria P.
    Pedroso, Jose A.
    Romagnoli, Jacopo
    Citterio, Franco
    CLINICAL TRANSPLANTATION, 2013, 27 (04) : E359 - E367
  • [33] Everolimus with Early Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients-12 Month Efficacy and Safety Results from H2304 Study
    Fung, J.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Koneru, B.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 28 - 28
  • [34] EFFECT OF EVEROLIMUS WITH REDUCED TACROLIMUS ON RENAL FUNCTION (RF) AFTER LIVING-DONOR LIVER TRANSPLANTATION (LDLT): 12-MONTH RESULTS FROM AN INTERNATIONAL RANDOMIZED TRIAL (NCT01888432)
    Braun, F.
    Settmacher, U.
    Lopez, P. M.
    Sips, C.
    Lieb, S.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 26 - 26
  • [35] Efficacy and safety outcomes among de novo renal transplant recipients managed by C2 monitoring of cyclosporine A microemulsion:: Results of a 12-month, randomized, multicenter study
    Stefoni, S
    Midtved, K
    Cole, E
    Thervet, E
    Cockfield, S
    Buchler, M
    Toselli, L
    Pallardo, LM
    Schena, FP
    Pilmore, H
    Kessler, M
    Chadban, S
    Carreño, CA
    TRANSPLANTATION, 2005, 79 (05) : 577 - 583
  • [36] Early Use of Everolimus Plus Reduced Tacrolimus vs Standard Tacrolimus in De Novo Livertransplant Recipients: 12 Months Efficacy and Safety Data from HEPHAISTOS Study
    Nashan, B.
    Schemmer, P.
    Schlitt, H.
    Pascher, A.
    Klein, C.
    Neumann, U.
    Kroeger, I.
    Wimmer, P.
    Braun, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 333 - 333
  • [37] SAFETY AND EFFICACY OF EARLY USE OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA
    Schlitt, H. J.
    Nashan, B.
    Schemmer, P.
    Pascher, A.
    Klein, C. G.
    Neumann, U.
    Kroeger, I.
    Wimmer, P.
    Braun, F.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 25 - 25
  • [38] Everolimus-Facilitated Reduction Of Tacrolimus Provides Comparable Efficacy And Superior Renal Function Versus Standard Tacrolimus In De Novo Liver Transplant Recipients: 24-Month Results Of A Randomized Trial
    Saliba, Faouzi
    De Simone, Paolo
    Nevens, Frederik
    De Carlis, Luciano
    Metselaar, Herold
    Beckebaum, Susanne
    Jonas, Sven
    Sudan, Debra
    Fischer, Lutz
    Fung, John J.
    Dong, Gaohong
    Lopez, Patricia M.
    Junge, Guido
    HEPATOLOGY, 2012, 56 (06) : 1519 - 1519
  • [39] 6-AND 12-MONTH RESULTS OF A PROSPECTIVE, MULTI-CENTER, RANDOMIZED, TRIAL COMPARING SAFETY AND EFFECTIVENESS OF COOLED RADIOFREQUENCY ABLATION TO CORTICOSTEROID INJECTION FOR MANAGEMENT OF OSTEOARTHRITIC KNEE PAIN
    Desai, M. J.
    Davis, T.
    Loudermilk, E.
    DePalma, M.
    Hunter, C.
    Lindley, D.
    Patel, N.
    Choi, D.
    Soloman, M.
    Gupta, A.
    Buvanendran, A.
    Kapural, L.
    OSTEOARTHRITIS AND CARTILAGE, 2018, 26 : S312 - S312
  • [40] ER-TACROLIMUS PLUS EVEROLIMUS VS ER-TACROLIMUS PLUS MMF IN PRIMARY DECEASED DONOR KIDNEY TRANSPLANTATION: 1-YEAR RESULTS OF SINGLE CENTER, OPEN LABEL, PROSPECTIVE, RANDOMIZED CLINICAL TRIAL
    Favi, Evaldo
    Silvestrini, Nicola
    Pedroso, Jose Alberto
    Salerno, Maria Paola
    Spagnoletti, Gionata
    Romagnoli, Jacopo
    Citterio, Franco
    TRANSPLANT INTERNATIONAL, 2013, 26 : 241 - 241
12345